(Alliance News) - Sweden's Recipharm AB on Tuesday said German regulators have approved its takeover of London-listed medical devices maker Consort Medical PLC.
The offer still needs to approval from competition regulators in Ireland, however, the pharmaceutical firm said.
Under the offer, a unit of Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort, including debt.
Consort shares were 0.5% lower at 1,030.00p each in London on Tuesday afternoon.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
